Volume 13, Number 1—January 2007
Dispatch
Reemergence of Endemic Chikungunya, Malaysia
Table
Patient | Chikungunya | Dengue fever | |||||||
---|---|---|---|---|---|---|---|---|---|
Age (y) | Sex | PCR† | Serology | Culture | PCR‡ | Serology | |||
E1 | E2 | nsP1 | IgM | IgG | IgM | ||||
6 | M | + | + | + | – | − | +§ | − | − |
34 | M | + | + | + | – | − | +¶ | − | − |
40 | M | + | + | + | – | − | +# | − | − |
26 | F | + | + | + | – | − | +** | ND | − |
62 | M | + | + | + | – | − | −†† | ND | − |
(day 5 after onset) | |||||||||
– | – | – | + | + | ND | ND | ND | ||
(day 15 after onset) |
*IgM, immunoglobulin M; IgG, immunoglobulin G; +, positive; −, negative; ND, not determined.
†PCR amplifications were performed for detection of envelope glycoprotein E1 (E1), glycoprotein E2 (E2), and nonstructural protein 1 (nsP1) genes of chikungunya virus.
‡Multiplex PCR amplifications were performed for detection of dengue virus type 1−4.
§Isolate MY/0306/BP37348.
¶Isolate MY/0306/BP37350.
#Isolate MY/0306/BP37352.
**Isolate MY/0406/BP37437.
††Isolate MY/0306/BP34198.
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.